By Business/Source
Currency:USD
2022/FY
Stock NameRevenueRatio
Discovery, development, and commercialization of allogeneic gamma delta T cell therapies for24.99M100.00%
By Country/Region
Currency:USD
2022/FY
Stock NameRevenueRatio
United States24.99M100.00%